4.5 Review

Progress and prospects: Zinc-finger nucleases as gene therapy agents

Journal

GENE THERAPY
Volume 15, Issue 22, Pages 1463-1468

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2008.145

Keywords

zinc-finger nucleases; gene targeting; nonhomologous end joining; homologous recombination

Funding

  1. NIGMS NIH HHS [R01 GM078571-02, R01 GM078571, R01 GM078571-03, R01 GM078571-01] Funding Source: Medline

Ask authors/readers for more resources

Zinc-finger nucleases (ZFNs) are powerful tools for experimental gene manipulation. A number of recent papers have shown how this technology can be applied effectively to models of human gene therapy. Significant target genes and useful methods of ZFN delivery have been reported. Important strides have been made in minimizing toxic side effects observed with some ZFNs, which bodes well for their ultimate safety. New tools are available for the design and testing of ZFNs for new target genes. Applications of ZFNs to stem cells have been described, and genuine gene therapy trials appear to be on the immediate horizon.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available